The move follows a joint investigation by the Tamil Nadu and Madhya Pradesh drug authorities, which found DEG contamination in samples of Coldrif, produced by Sresan Pharma, Kanchipuram. The discovery and the falloutThe alarm was first raised in Chhindwara, Madhya Pradesh, where several children died after consuming cough syrup. Following the report, the Tamil Nadu government banned the sale and manufacture of Coldrif, while Madhya Pradesh ordered an immediate withdrawal of the product from pharmacies. Regulatory crackdown widensActing on the preliminary findings, the CDSCO has dispatched inspection teams to multiple states, including Tamil Nadu, Maharashtra, Himachal Pradesh, Uttar Pradesh, Gujarat, and Uttarakhand. Meanwhile, families of the victims in Madhya Pradesh and Rajasthan are demanding criminal charges against the manufacturer and distributors.